Truist Securiti Weighs in on UnitedHealth Group Incorporated’s Q2 2021 Earnings (NYSE:UNH)

UnitedHealth Group Incorporated (NYSE:UNH) – Research analysts at Truist Securiti boosted their Q2 2021 EPS estimates for UnitedHealth Group in a note issued to investors on Tuesday, April 20th. Truist Securiti analyst D. Macdonald now forecasts that the healthcare conglomerate will post earnings per share of $4.44 for the quarter, up from their previous forecast of $4.39. Truist Securiti also issued estimates for UnitedHealth Group’s Q3 2021 earnings at $4.40 EPS, Q4 2021 earnings at $4.34 EPS, FY2021 earnings at $18.48 EPS and FY2022 earnings at $21.08 EPS.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Wednesday, April 14th. The healthcare conglomerate reported $5.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.38 by $0.93. The company had revenue of $70.20 billion for the quarter, compared to the consensus estimate of $69.13 billion. UnitedHealth Group had a return on equity of 27.53% and a net margin of 6.62%. UnitedHealth Group’s revenue for the quarter was up 9.0% on a year-over-year basis. During the same quarter in the prior year, the business posted $3.72 earnings per share.

A number of other equities analysts also recently issued reports on the company. Morgan Stanley increased their price target on UnitedHealth Group from $462.00 to $515.00 and gave the stock an “overweight” rating in a research report on Thursday. Stephens increased their target price on UnitedHealth Group from $415.00 to $425.00 and gave the company an “overweight” rating in a report on Thursday. BMO Capital Markets increased their target price on UnitedHealth Group from $410.00 to $435.00 and gave the company a “market perform” rating in a report on Thursday. Credit Suisse Group increased their target price on UnitedHealth Group from $415.00 to $430.00 and gave the company an “outperform” rating in a report on Thursday. Finally, Bank of America reissued a “buy” rating and set a $415.00 target price on shares of UnitedHealth Group in a report on Thursday, January 21st. Three analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company’s stock. UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $409.61.

Shares of UNH stock opened at $396.54 on Thursday. The company has a market capitalization of $374.86 billion, a P/E ratio of 22.78, a P/E/G ratio of 1.55 and a beta of 0.74. The business’s 50 day moving average is $367.37 and its two-hundred day moving average is $345.20. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.59. UnitedHealth Group has a 12-month low of $273.71 and a 12-month high of $401.48.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 23rd. Shareholders of record on Monday, March 15th were paid a dividend of $1.25 per share. The ex-dividend date of this dividend was Friday, March 12th. This represents a $5.00 annualized dividend and a yield of 1.26%. UnitedHealth Group’s dividend payout ratio (DPR) is 33.09%.

In other UnitedHealth Group news, Director Richard T. Burke sold 2,500 shares of the firm’s stock in a transaction on Monday, April 19th. The stock was sold at an average price of $391.25, for a total transaction of $978,125.00. Following the completion of the sale, the director now owns 154,181 shares of the company’s stock, valued at $60,323,316.25. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CAO Thomas E. Roos sold 619 shares of the firm’s stock in a transaction on Tuesday, February 9th. The stock was sold at an average price of $323.90, for a total value of $200,494.10. Following the sale, the chief accounting officer now directly owns 31,908 shares of the company’s stock, valued at approximately $10,335,001.20. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,119 shares of company stock valued at $5,440,869. 0.80% of the stock is owned by insiders.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Carroll Financial Associates Inc. boosted its position in shares of UnitedHealth Group by 0.9% during the fourth quarter. Carroll Financial Associates Inc. now owns 3,200 shares of the healthcare conglomerate’s stock worth $1,122,000 after buying an additional 30 shares during the period. Harfst & Associates Inc. increased its holdings in UnitedHealth Group by 1.2% during the 4th quarter. Harfst & Associates Inc. now owns 2,565 shares of the healthcare conglomerate’s stock worth $899,000 after purchasing an additional 31 shares during the period. Harvest Group Wealth Management LLC raised its position in UnitedHealth Group by 13.3% in the 4th quarter. Harvest Group Wealth Management LLC now owns 264 shares of the healthcare conglomerate’s stock valued at $93,000 after purchasing an additional 31 shares in the last quarter. South State CORP. raised its position in UnitedHealth Group by 0.6% in the 4th quarter. South State CORP. now owns 5,008 shares of the healthcare conglomerate’s stock valued at $1,757,000 after purchasing an additional 32 shares in the last quarter. Finally, Private Portfolio Partners LLC raised its position in UnitedHealth Group by 2.0% in the 4th quarter. Private Portfolio Partners LLC now owns 1,661 shares of the healthcare conglomerate’s stock valued at $582,000 after purchasing an additional 32 shares in the last quarter. Institutional investors and hedge funds own 86.03% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.

Read More: Resistance Level

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.